We evaluate CRO/CDMO partners using AI-assisted screening across infrastructure, talent density, quality culture, and regulatory track record. Every candidate is scored against a standardized qualification framework, so sponsors move from a broad list of vendors to a validated shortlist quickly, without compromising on diligence.
AI-assisted evaluation of infrastructure, talent density, quality culture, and regulatory behavior.
Deep-dive audits for OEB-5/HPAPI containment, sterile injectables, and advanced modalities.
Zero vendor ties. Absolute objectivity.
A dedicated program management office sits above every workstream, tracking milestones, budgets, and cross-functional risk in one place. Structured steering committees and stage-gate reviews mean there's a single point of accountability, so nothing slips through the cracks between departments or vendors.
Our regulatory and quality experts guide programs through global submission strategy and health authority interactions, from pre-IND planning to inspection readiness. The goal is a defensible, compliant development package built in from day one, not patched together before a filing deadline.
Senior program leads coordinating multi-vendor, multi-site execution.
Real-time visibility into deviations, delays, and capacity stress.
Bottlenecks are addressed before they become regulatory events.
Real-time monitoring tracks enrollment, supply chain, and regulatory shifts as they happen, paired with predictive analytics that flag risk before it becomes delay. Sponsors get proactive alerts and recommendations, not a static report after the damage is done.
We stay hands-on through every process and technology transfer between development and manufacturing sites, running gap assessments and readiness checks before scale-up rather than after
Press Enter to search